Cell‐Based Therapies: The Nonresponder

Cell‐based therapies have come of age and several phase III trials are now being conducted. Cell‐based therapies, especially involving mesenchymal stem cells (MSCs), have substantial nonresponder rates, as has been reported in some current clinical trials. This high rate is expected as the MSCs are...

Descripción completa

Detalles Bibliográficos
Autor principal: Caplan, Arnold I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216418/
https://www.ncbi.nlm.nih.gov/pubmed/30251411
http://dx.doi.org/10.1002/sctm.18-0074